125 related articles for article (PubMed ID: 398183)
1. The effect of gemfibrozil on serum lipids in diabetic patients.
Konttinen A; Kuisma I; Ralli R; Pohjola S; Ojala K
Ann Clin Res; 1979 Dec; 11(6):240-5. PubMed ID: 398183
[TBL] [Abstract][Full Text] [Related]
2. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
Nikkilä EA; Ylikahri R; Huttunen JK
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
[TBL] [Abstract][Full Text] [Related]
3. Effect of gemfibrozil on serum lipid levels.
Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
Artery; 1980; 7(3):224-31. PubMed ID: 7008748
[TBL] [Abstract][Full Text] [Related]
4. Gemfibrozil in a group of diabetics.
de Salcedo I; Gorringe AL; Silva JL; Santos JA
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):64-70. PubMed ID: 1019155
[TBL] [Abstract][Full Text] [Related]
5. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
Nye ER; Sutherland WH; Temple Wa
N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
[TBL] [Abstract][Full Text] [Related]
6. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
Romics L; Karádi I; Rozenberczki M; Kammerer L
Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
[TBL] [Abstract][Full Text] [Related]
7. Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
Vessby B; Lithell H; Boberg J; Hellsing K; Werner I
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):32-7. PubMed ID: 798194
[TBL] [Abstract][Full Text] [Related]
8. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
9. Effects of gemfibrozil on serum lipids.
Samuel P
Am J Med; 1983 May; 74(5A):23-7. PubMed ID: 6573843
[TBL] [Abstract][Full Text] [Related]
10. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
Sirtori CR; Franceschini G; Gianfranceschi G; Sirtori M; Montanari G; Tremoli E; Maderna P; Colli S; Zoppi F
J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
[TBL] [Abstract][Full Text] [Related]
11. Effect of gemfibrozil on serum lipids in man.
Fenderson RW; Deutsch S; Menachemi E; Chin B; Samuel P
Angiology; 1982 Sep; 33(9):581-93. PubMed ID: 6751166
[TBL] [Abstract][Full Text] [Related]
12. Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure.
Pasternack A; Vänttinen T; Solakivi T; Kuusi T; Korte T
Clin Nephrol; 1987 Apr; 27(4):163-8. PubMed ID: 3555908
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of lipoprotein changes during gemfibrozil treatment.
Janus ED; Costa D; Ononogbu IC; Lewis B
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):76-7. PubMed ID: 1019156
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
17. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Kesäniemi YA; Grundy SM
JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
[TBL] [Abstract][Full Text] [Related]
18. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
[TBL] [Abstract][Full Text] [Related]
19. The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).
Elkeles RS
Diabete Metab; 1991 May; 17(1 Pt 2):197-200. PubMed ID: 1936476
[TBL] [Abstract][Full Text] [Related]
20. [Blood lipid/variations in the diabetic. I. Preventive note].
Sassu G; Simonetti M
Clin Ter; 1976 Feb; 76(3):261-4. PubMed ID: 183931
[No Abstract] [Full Text] [Related]
[Next] [New Search]
